REHOVOT, Israel, March 6,
2023 /PRNewswire/ -- Lavie Bio Ltd., a
subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), and a
leading ag-biological company focusing on improving food quality,
sustainability, and agriculture productivity through the
introduction of microbiome-based products, today announced in that
its management will be sponsoring and participating at the World
Agri-Tech Conference in San
Francisco, taking place between March
14-15, 2023.
Lavie Bio's EVP Commercial & US General Manager,
Russ Putland, will be hosting a
lunchtime roundtable discussion on March
15, entitled, "Farm to Fork or Fork to Farm", taking
place during the conference. The discussion will focus into aspects
of the sustainability value chain, starting with the consumer right
down to the farmgate.
Lavie Bio is a one of the sponsors of the World Agri-Tech
Innovation Summit, in company with some of the world leading
technology companies as well as key ag-tech players. The Summit has
become the annual meeting place for the global ag-tech ecosystem,
with over 2,000 growers, agribusiness leaders, technology pioneers
and investors coming together to exchange insights, be inspired,
and identify future partners.
Investors or analysts attending the conference and wish to meet
with the management of Lavie Bio and Evogene, are welcome to
contact the Lavie Bio team or reach out through World Agri-Tech
conference channels.
About Lavie Bio Ltd.
Lavie Bio, a subsidiary of Evogene Ltd., aims to improve food
quality, sustainability, and agriculture productivity through the
introduction of microbiome-based ag-biological products. Lavie Bio
utilizes a proprietary computational predictive platform, the BDD
platform, powered by Evogene's proprietary MicroBoost
AI tech-engine, harnessing the power of big data,
artificial intelligence, and advanced informatics, for the
discovery, optimization and development of bio-stimulant and
bio-pesticide products.
For more information, please visit www.lavie-bio.com.
About Evogene Ltd.:
Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology
company aiming to revolutionize the development of life-science
based products by utilizing cutting edge technologies to increase
the probability of success while reducing development time and
cost. Evogene established three unique tech-engines -
MicroBoost AI, ChemPass
AI and GeneRator AI – leveraging Big Data
and Artificial Intelligence and incorporating deep
multidisciplinary understanding in life sciences. Each
tech-engine is focused on the discovery and development of
products based on one of the following core components: microbes
(MicroBoost AI), small molecules (ChemPass AI), and
genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through
subsidiaries and strategic partnerships. Evogene's subsidiaries
currently utilize the tech-engines to develop human
microbiome-based therapeutics by Biomica, ag-biologicals by Lavie
Bio, ag-chemicals by AgPlenus, medical cannabis products by Canonic
and castor varieties, for the biofuel and other industries, by
Casterra.
For more information, please visit www.evogene.com
Contacts
|
|
Russ Putland, EVP
Commercial & GM USA
E: russel.putland@lavie-bio.com
T: +1 980 474
8170
|
Dor Kestecher, VP
Business Development
E:
dor.kestecher@lavie-bio.com
T: +972 52 363
3684
|
Kenny Green, Investor
Relations
E:
kenny.green@evogene.com
T: +1 212 378
8040
|
|
Logo:
https://mma.prnewswire.com/media/945133/lavie_bio.jpg
Logo: https://mma.prnewswire.com/media/1947468/Evogene.jpg
View original
content:https://www.prnewswire.com/news-releases/lavie-bio-to-host-a-round-table-discussion-and-is-a-sponsor-at-world-agri-tech-conference-in-san-francisco-301763156.html
SOURCE Lavie Bio